PKCι depletion initiates mitotic slippage-induced senescence in glioblastoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26208522)

Published in Cell Cycle on January 01, 2015

Authors

Ian J Restall1,2, Doris A E Parolin1, Manijeh Daneshmand1, Jennifer E L Hanson1, Manon A Simard1,2, Megan E Fitzpatrick1,2, Ritesh Kumar1,2, Sylvie J Lavictoire1, Ian A J Lorimer1,2,3

Author Affiliations

1: a Centre for Cancer Therapeutics; Ottawa Hospital Research Institute ; Ottawa , ON Canada.
2: b Department of Biochemistry ; Microbiology and Immunology; University of Ottawa ; Ottawa , ON Canada.
3: c Department of Medicine ; University of Ottawa ; Ottawa , ON Canada.

Articles cited by this

Hallmarks of cancer: the next generation. Cell (2011) 140.01

Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13

The serial cultivation of human diploid cell strains. Exp Cell Res (1961) 25.11

Telomeres shorten during ageing of human fibroblasts. Nature (1990) 23.97

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature (2007) 16.95

BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature (2005) 16.87

Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62

Tumour biology: senescence in premalignant tumours. Nature (2005) 10.15

The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol (2010) 7.58

A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell (2006) 6.96

BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet (2004) 6.85

MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature (2001) 6.36

Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science (1998) 5.62

A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev (2007) 5.07

Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell (2004) 4.90

Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell (2009) 4.76

Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc (2009) 4.47

Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr Biol (1998) 4.13

Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol (2006) 3.99

PML is induced by oncogenic ras and promotes premature senescence. Genes Dev (2000) 3.35

DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res (2002) 3.22

Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature (2010) 3.09

Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nat Rev Mol Cell Biol (2013) 3.01

Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res (2004) 2.79

Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell (2010) 2.45

Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res (2005) 2.42

Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci (2008) 2.41

APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol Cell (2007) 2.35

Origins and consequences of centrosome aberrations in human cancers. Int J Cancer (2006) 2.31

ANEUPLOIDY IN THE DEGENERATIVE PHASE OF SERIAL CULTIVATION OF HUMAN CELL STRAINS. Proc Natl Acad Sci U S A (1963) 2.25

Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol (2008) 1.89

Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res (2005) 1.84

Glioblastoma multiforme: a review of therapeutic targets. Expert Opin Ther Targets (2009) 1.38

Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp Gerontol (2001) 1.34

Inhibition of centrosome protein assembly leads to p53-dependent exit from the cell cycle. J Cell Biol (2006) 1.34

Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects. Cancer Res (2005) 1.32

Oncogenic RAS induces accelerated transition through G2/M and promotes defects in the G2 DNA damage and mitotic spindle checkpoints. J Biol Chem (2005) 1.28

High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. Cancer Res (2007) 1.24

The transforming acidic coiled coil 3 protein is essential for spindle-dependent chromosome alignment and mitotic survival. J Biol Chem (2007) 1.18

Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling. Oncogene (2006) 1.12

Protein kinase Cι expression and oncogenic signaling mechanisms in cancer. J Cell Physiol (2011) 1.08

PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. EMBO J (2002) 1.08

The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program. Oncogene (2010) 1.07

MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition. Oncotarget (2015) 1.05

Substrate degradation by the anaphase promoting complex occurs during mitotic slippage. Cell Cycle (2010) 1.03

Regulation of glioblastoma cell invasion by PKC iota and RhoB. Oncogene (2008) 1.02

Radiation-induced cellular senescence results from a slippage of long-term G2 arrested cells into G1 phase. Cell Cycle (2013) 0.97

Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence. Oncotarget (2011) 0.91

Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro. Br J Cancer (2009) 0.91

Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G₂ checkpoint arrest. J Cell Mol Med (2011) 0.89

The centrosome and mitotic spindle apparatus in cancer and senescence. Cell Cycle (2010) 0.89

Coordination of glioblastoma cell motility by PKCι. Mol Cancer (2010) 0.88

Polyploidy: the link between senescence and cancer. Curr Pharm Des (2010) 0.88

Failure of cell cleavage induces senescence in tetraploid primary cells. Mol Biol Cell (2014) 0.86

Repression of cancer cell senescence by PKCι. Oncogene (2011) 0.85

Cellular aging and centrosome aberrations. Ann N Y Acad Sci (2010) 0.83

A potential role for NEDD1 and the centrosome in senescence of mouse embryonic fibroblasts. Cell Death Dis (2010) 0.82

Centrosome aberrations associated with cellular senescence and p53 localization at supernumerary centrosomes. Oxid Med Cell Longev (2012) 0.79

Abnormal mitosis in hypertetraploid cells causes aberrant nuclear morphology in association with H2O2-induced premature senescence. Cytometry A (2008) 0.78